Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2018 Jan 25

PMID 29361803

Citations 22

Authors

Heiko Schulz

Christina Kuhn

Simone Hofmann

Doris Mayr

Sven Mahner

Udo Jeschke

Elisa Schmoeckel

Affiliations

Soon will be listed here.

Abstract

The evaluation of new prognostic factors that can be targeted in ovarian cancer diagnosis and therapy is of the utmost importance. Galectins are a family of carbohydrate binding proteins with various implications in cancer biology. In this study, the presence of galectin (Gal)-8 and -9 was investigated in 156 ovarian cancer samples using immunohistochemistry (IHC). Staining was evaluated using semi-quantitative immunoreactivity (IR) scores and correlated to clinical and pathological data. Different types of galectin expression were compared with respect to disease-free survival (DFS) and overall survival (OS). Gal-8 served as a new positive prognostic factor for the OS and DFS of ovarian cancer patients. Gal-9 expression determined the DFS and OS of ovarian cancer patients in two opposing ways-moderate Gal-9 expression was correlated with a reduced outcome as compared to Gal-9 negative cases, while patients with high Gal-9 expression showed the best outcome.

Citing Articles

[A lightweight recurrence prediction model for high grade serous ovarian cancer based on hierarchical transformer fusion metadata].

Cui S, Tang Y, Wan H, Wang R, Liu L Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024; 41(4):807-817.

PMID: 39218608 PMC: 11366459. DOI: 10.7507/1001-5515.202308009.

Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer.

Beyer S, Wehrmann M, Meister S, Trillsch F, Ganster F, Schmoeckel E Int J Mol Sci. 2024; 25(13).

PMID: 39000016 PMC: 11241125. DOI: 10.3390/ijms25136907.

Significance of the Galectin-8 Immunohistochemical Profile in Ovarian Cancer.

Avadanei E, Caruntu I, Amalinei C, Pavaleanu I, Giusca S, Rusu A Biomedicines. 2024; 12(2).

PMID: 38397905 PMC: 10887174. DOI: 10.3390/biomedicines12020303.

Characterization of T cell receptor repertoire in penile cancer.

Zhang J, Wang Y, Huang Y, Tan X, Xu J, Yan Q Cancer Immunol Immunother. 2024; 73(2):24.

PMID: 38280010 PMC: 10822009. DOI: 10.1007/s00262-023-03615-z.

Galectin-8 Immunohistochemical Profile in Pancreatic Ductal Adenocarcinoma: Emerging Evidence for Its Prognostic Role.

Rusu A, Caruntu I, Lozneanu L, Ciobanu D, Amalinei C, Giusca S Diagnostics (Basel). 2023; 13(20).

PMID: 37892036 PMC: 10606265. DOI: 10.3390/diagnostics13203215.

References

Metz C, Doger R, Riquelme E, Cortes P, Holmes C, Shaughnessy R . Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells. Biol Res. 2016; 49(1):33. PMC: 4962418. DOI: 10.1186/s40659-016-0091-6. View

Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X . Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer. Cell Death Dis. 2014; 5:e991. PMC: 4040687. DOI: 10.1038/cddis.2013.526. View

Davidson B, Trope C . Ovarian cancer: diagnostic, biological and prognostic aspects. Womens Health (Lond). 2014; 10(5):519-33. DOI: 10.2217/whe.14.37. View

Jiang J, Jin M, Kong F, Cao D, Ma H, Jia Z . Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer. PLoS One. 2013; 8(12):e81799. PMC: 3858245. DOI: 10.1371/journal.pone.0081799. View

Heusschen R, Griffioen A, Thijssen V . Galectin-9 in tumor biology: a jack of multiple trades. Biochim Biophys Acta. 2013; 1836(1):177-85. DOI: 10.1016/j.bbcan.2013.04.006. View

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F . Introduction to galectins. Glycoconj J. 2004; 19(7-9):433-40. DOI: 10.1023/B:GLYC.0000014072.34840.04. View

Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin M, Nishi N . Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer. 2002; 99(6):809-16. DOI: 10.1002/ijc.10436. View

Hadari Y, Paz K, Dekel R, Mestrovic T, Accili D, Zick Y . Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem. 1995; 270(7):3447-53. DOI: 10.1074/jbc.270.7.3447. View

10.

Facciabene A, Motz G, Coukos G . T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012; 72(9):2162-71. PMC: 3342842. DOI: 10.1158/0008-5472.CAN-11-3687. View

11.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

12.

Hermans C, Anz D, Engel J, Kirchner T, Endres S, Mayr D . Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers. PLoS One. 2014; 9(11):e111757. PMC: 4218808. DOI: 10.1371/journal.pone.0111757. View

13.

Barondes S, Cooper D, Gitt M, Leffler H . Galectins. Structure and function of a large family of animal lectins. J Biol Chem. 1994; 269(33):20807-10. View

14.

Troncoso M, Ferragut F, Bacigalupo M, Cardenas Delgado V, Nugnes L, Gentilini L . Galectin-8: a matricellular lectin with key roles in angiogenesis. Glycobiology. 2014; 24(10):907-14. DOI: 10.1093/glycob/cwu054. View

15.

Wang F, He W, Zhou H, Yuan J, Wu K, Xu L . The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft. Cell Immunol. 2008; 250(1-2):68-74. DOI: 10.1016/j.cellimm.2008.01.006. View

16.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

17.

Nishi N, Itoh A, Shoji H, Miyanaka H, Nakamura T . Galectin-8 and galectin-9 are novel substrates for thrombin. Glycobiology. 2006; 16(11):15C-20C. DOI: 10.1093/glycob/cwl028. View

18.

Thibault B, Castells M, Delord J, Couderc B . Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev. 2013; 33(1):17-39. DOI: 10.1007/s10555-013-9456-2. View

19.

Kim H, Jeon H, Lee J, Sung C, Do I, Choi C . Clinical significance of galectin-7 in epithelial ovarian cancer. Anticancer Res. 2013; 33(4):1555-61. View

20.

Thijssen V, Hulsmans S, Griffioen A . The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. Am J Pathol. 2008; 172(2):545-53. PMC: 2312370. DOI: 10.2353/ajpath.2008.070938. View